DURECT Corporation

0.4137-0.0050-1.19%Vol 568.66K1Y Perf -76.21%
May 18th, 2022 16:00 DELAYED
BID0.4025 ASK0.4398
Open0.4061 Previous Close0.4187
Pre-Market- After-Market0.44
 - -  0.03 6.31%
Target Price
5.67 
Analyst Rating
Strong Buy 1.00
Potential %
1.27K 
Finscreener Ranking
★★★★     53.29
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★     46.94
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★+     43.51
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
3.23 
Earnings Rating
Buy
Market Cap94.23M 
Earnings Date
4th May 2022
Alpha0.01 Standard Deviation0.26
Beta1.46 

Today's Price Range

0.40030.4350

52W Range

0.36601.85

5 Year PE Ratio Range

-87.00-8.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
5.17%
1 Month
-4.84%
3 Months
-37.98%
6 Months
-62.95%
1 Year
-76.21%
3 Years
-44.17%
5 Years
-65.40%
10 Years
-44.91%

TickerPriceChg.Chg.%
DRRX0.4137-0.0050-1.19
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
7.20
7.80
0.32
0.51
-16.20
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
85.80
-254.50
-252.40
-74.60
-2.29
RevenueValueIndustryS&P 500US Markets
13.68M
0.06
-12.98
-7.38
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.05-0.050.00
Q04 2021-0.05-0.0340.00
Q03 2021-0.04-0.040.00
Q02 2021-0.04-0.040.00
Q01 2021-0.05-0.050.00
Q04 2020-0.03-0.04-33.33
Q03 2020-0.04-0.05-25.00
Q02 20200.040.0775.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.040.00-
9/2022 QR-0.05-25.00Negative
12/2022 FY-0.19-18.75Negative
12/2023 FY-0.09--
Next Report Date-
Estimated EPS Next Report-0.05
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume568.66K
Shares Outstanding227.76K
Shares Float198.08M
Trades Count3.27K
Dollar Volume234.60K
Avg. Volume943.33K
Avg. Weekly Volume985.93K
Avg. Monthly Volume1.03M
Avg. Quarterly Volume815.05K

DURECT Corporation (NASDAQ: DRRX) stock closed at 0.4187 per share at the end of the most recent trading day (a 11.24% change compared to the prior day closing price) with a volume of 1.11M shares and market capitalization of 94.23M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 95 people. DURECT Corporation CEO is James E. Brown.

The one-year performance of DURECT Corporation stock is -76.21%, while year-to-date (YTD) performance is -57.53%. DRRX stock has a five-year performance of -65.4%. Its 52-week range is between 0.366 and 1.845, which gives DRRX stock a 52-week price range ratio of 3.23%

DURECT Corporation currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 1.92, a price-to-sale (PS) ratio of 6.27, a price to cashflow ratio of 288.60, a PEG ratio of 2.32, a ROA of -38.89%, a ROC of -39.09% and a ROE of -59.26%. The company’s profit margin is -2.29%, its EBITDA margin is -252.40%, and its revenue ttm is $13.68 Million , which makes it $0.06 revenue per share.

Of the last four earnings reports from DURECT Corporation, there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. DURECT Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for DURECT Corporation is Strong Buy (1), with a target price of $5.67, which is +1 270.56% compared to the current price. The earnings rating for DURECT Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DURECT Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DURECT Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 16.62, ATR14 : 0.05, CCI20 : -48.67, Chaikin Money Flow : -0.20, MACD : -0.03, Money Flow Index : 38.16, ROC : -6.96, RSI : 45.46, STOCH (14,3) : 36.72, STOCH RSI : 1.00, UO : 39.55, Williams %R : -63.28), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DURECT Corporation in the last 12-months were: Gail M. Farfel (Buy at a value of $9 534), Judith J. Robertson (Buy at a value of $118 000), Simon X. Benito (Buy at a value of $20 360)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

CEO: James E. Brown

Telephone: +1 408 777-1417

Address: 10260 Bubb Road, Cupertino 95014, CA, US

Number of employees: 95

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

55%45%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

News

Stocktwits